Stifel’s latest update, using DealForma data, reports key biopharma market events. Highlights include hawkish Fed impacts on biotech stocks, Biogen’s $1.15B HI-Bio acquisition, and $1.7B in follow-on offerings. Checkout the Stifel story.
Stifel’s latest update, using DealForma data, reports key biopharma market events. Highlights include hawkish Fed impacts on biotech stocks, Biogen’s $1.15B HI-Bio acquisition, and $1.7B in follow-on offerings. Checkout the Stifel story.
DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.
Database
Company
Comparisons
Website Design by Once Interactive
